DexCom

YTD

ALL

Trade DexCom 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DXCM

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE.

CEO

Jacob S. Leach

CEOJacob S. Leach

Employees

11,100

Employees11,100

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1999

Founded1999

Employees

11,100

Employees11,100

DXCM Key Statistics

Market cap

31.98B

Market cap31.98B

Price-Earnings ratio

34.46

Price-Earnings ratio34.46

Dividend yield

—

Dividend yield—

Average volume

6.29M

Average volume6.29M

High today

$85.06

High today$85.06

Low today

$82.09

Low today$82.09

Open price

$82.49

Open price$82.49

Volume

4.58M

Volume4.58M

52 Week high

$87.85

52 Week high$87.85

52 Week low

$54.11

52 Week low$54.11

Stock Snapshot

DexCom(DXCM) stock is priced at $83.99, giving the company a market capitalization of 31.98B. It carries a P/E multiple of 34.46.

During the trading session on 2026-08-08, DexCom(DXCM) shares reached a daily high of $85.06 and a low of $82.09. At a current price of $83.99, the stock is +2.3% higher than the low and still -1.2% under the high.

Trading volume for DexCom(DXCM) stock has reached 4.58M, versus its average volume of 6.29M.

The stock's 52-week range extends from a low of $54.11 to a high of $87.85.

DXCM News

MarketWatch 1d

DexCom Inc. stock outperforms competitors on strong trading day - MarketWatch

...

Simply Wall St 3d

DexCom Raised Full Year Guidance, Is The Upside Already Priced In?

DexCom (DXCM) drew fresh attention after reporting second quarter 2026 results with higher sales and earnings, and raised full year revenue guidance to a range...

TipRanks 4d

DexCom price target raised to $96 from $86 at Argus

Argus analyst Steve Silver raised the firm’s price target on DexCom (DXCM) to $96 from $86 and keeps a Buy rating on the shares. DexCom’s strong Q2 execution an...

Analyst ratings

84%

of 31 ratings

Buy

83.9%

Hold

16.1%

Sell

More DXCM News

Nasdaq 5d

DXCM Crosses Above Average Analyst Target

In recent trading, shares of DexCom Inc (Symbol: DXCM) have crossed above the average analyst 12-month target price of $86.11, changing hands for $87.31/share....

The Motley Fool 5d

DexCom Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. Thursday, July 30, 2026 at 4:30 p.m. ET CALL PARTICIPANTS senior vice president of finance and investor relations - Sean Christen...

Simply Wall St 6d

DexCom Is Up 16.6% After Raising 2026 Revenue Guidance And Margin Outlook - Has The Bull Case Changed?

In late July 2026, DexCom, Inc. reported second-quarter results showing revenue of US$1,308.4 million and net income of US$249.1 million, and raised its full-ye...

People also own

Based on the portfolios of people who own DXCM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.